Discussion The morbidity and mortality of patients with CRC currently show an increasing trend ( 22 ).
← all excerpts
α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway.
1
—
—
Discussion The morbidity and mortality of patients with CRC currently show an increasing trend ( 22 ).